SCHEMBL20022591

SCHEMBL20022591

Cc1ccc(C#Cc2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.74
SMN1; SMN2 Q16637 1/20 0.74
SRD5A2 P31213 3/20 0.65
RARB P10826 3/20 0.63
RARG P13631 3/20 0.63
VCP P55072 1/20 0.56
FFAR1 O14842 2/20 0.55
PTPN11 Q06124 1/20 0.55
TP53 P04637 1/20 0.52
TSHR P16473 1/20 0.52
RARA P10276 2/20 0.51
CYP26A1 O43174 1/20 0.51
CYP3A4 P08684 1/20 0.51
CRABP2 P29373 1/20 0.51
CES2 O00748 2/20 0.50
CES1 P23141 2/20 0.50
LMNA P02545 1/20 0.50
ACACB O00763 1/20 0.49
RXRA P19793 1/20 0.48
RXRB P28702 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16103317 0.94 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2SRD5A2RARBRARG
SCHEMBL29789030 0.89 RARB (0.69) ALDH1A1SMN1; SMN2SRD5A2RARBRARG
SCHEMBL69572 0.89 RARB (0.69) ALDH1A1SMN1; SMN2SRD5A2RARBRARG
Hydrochloric Acid SCHEMBL5666955 0.86 RARB (0.67) ALDH1A1SMN1; SMN2SRD5A2RARBRARG
Terephthalic Acid SCHEMBL15994097 0.86 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2SRD5A2TP53TSHR
4-Methylbenzoic Acid SCHEMBL11366477 0.86 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2SRD5A2TP53TSHR
4-Methylbenzoic Acid SCHEMBL93638 0.86 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2SRD5A2TP53TSHR
4-Methylbenzoic Acid SCHEMBL1331178 0.86 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2SRD5A2TP53TSHR
Terephthalic Acid SCHEMBL526449 0.86 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2SRD5A2TP53TSHR
4-Methylbenzoic Acid SCHEMBL147465 0.86 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2SRD5A2TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022025636-A1 DUAL REGULATOR FOR MGLUR5 AND 5-HT2A RECEPTORS AND USE THEREOF 주식회사 비보존 2022-02-03 WO disclosed
US-20180093251-A1 POROUS COORDINATION POLYMER AND GAS STORAGE USING THE SAME PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2018-04-05 US disclosed
US-20100190766-A1 ANTIBACTERIAL AGENTS ACHAOGEN, INC. (US) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190766-A1 ANTIBACTERIAL AGENTS MRPL21, SI, ABCB11 ALDH1A1 687/4885SMN1; SMN2 2202/4885SRD5A2 609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.